[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616388":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":7,"responsibleParty":18,"collaborators":7,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":27,"acronym":7,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":30,"maxAge":31,"enrollmentInfo":32,"targetDuration":35,"studyType":36,"phases":7,"briefSummary":37,"conditions":38,"keywords":7,"overallStatus":41,"whyStopped":7,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Hussein Abdelrahem Hussein, resident","CONTACT","0201151220581","hussein.17289842@med.aun.eg",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Eman Mohamed Hussein, professor","020 10 05850632","emankhedr99@aun.edu.eg",{"type":19,"investigatorFullName":20,"investigatorTitle":21,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Hussein Abd Elrahim Hussein Mohamed","Resident doctor","100616388","multiple-sclerosis-versus-neuromyelitis-optica-spectrum-disorder-100616388",false,"NCT07304960","Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder","Comparative Study Between Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder Patients in Assiut Hospitals Clinical and Laboratory Study","Inclusion Criteria:1- Both sex 2- Aged between 18 and 50 years. All included patients were in a clinically stable phase and had not experienced a relapse within at least three months before blood sampling. 3- All patients diagnosed as MS patients either naive or on disease modifying therapies according to The new diagnostic criteria MacDonalds 2024 4- DMT-naïve NMOSD patients: Diagnosed with MS based on the 2017 McDonald Criteria (Thompson et al., 2018)\n\n5- An informed consent will be obtained from all the patients; the study will be approved by ethical committee in faculty of Medicine Assiut University\n\n\\-\n\n1\\_ Presence of other disorder that mimic MS or NMOSD 3\\_ Patients failed to commit to the follow up visits and regular MRI scans 4\\_ Patients refused to sign the written informed consent\n\nExclusion Criteria:\n\n* 1\\_ Presence of other disorder that mimic MS or NMOSD 3\\_ Patients failed to commit to the follow up visits and regular MRI scans 4\\_ Patients refused to sign the written informed consent","ALL","18 Years","50 Years",{"count":33,"type":34},100,"ESTIMATED","6 Months","OBSERVATIONAL","The aim of this work is to do a detailed comparison between multiple sclerosis and Neuromyelitis Optica Spectrum Disorder due to delicate similarities between both diseases and wide rang of management and follow up of the patients",[39,40],"MS (Multiple Sclerosis)","NMO Spectrum Disorder (NMOSD)","NOT_YET_RECRUITING","2025-12-12",{"date":44,"type":45},"2025-12-26","ACTUAL",{"date":47,"type":34},"2026-01-01",{"date":49,"type":34},"2030-12-22",{"name":5,"class":6}]